RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

If the FDA's lack of timely response were expected to be delayed, again a procedure which is probably consistent, then Stoll should have known this and done the PR immediately after the rejection. This would have created the dead cat bounce and sustained higher share price levels back in the October 12th-15th range. That is all, as a shareholder, I was looking for. Although Stoll's efforts lack in this area, it is his responsibility to perform these little dances to benefit shareholder value.....an immediate response would have sustained investor confidence in that we would have been given the opportunity to believe aggresive contigent plans were indeed in place. The uncertainty surrounding the delay created an unstable bottom in the SP. Stoll could have controlled this with the same words he used today.

You got to admit the National Geo article should spawn plenty of new interest. Good timing. A small carrot but a carrot none the less. It will be interesting to see how COR is portrayed and projected.

Naked, it must be hard to maintain your position of a scam when investigative journalists, who are willing to expose and do invasive articles on such, are willing to feature COR, in a light that is entirely different....a pioneer in memory enhacement therapies.